Genetic sequencing company will take full ownership of group developing liquid biopsy
Home/FT/Illumina agrees $8bn deal for cancer screening start-up Grail FT Illumina agrees $8bn deal for cancer screening start-up Grail Financial Times0 Less than a minute Facebook X LinkedIn Genetic sequencing company will take full ownership of group developing liquid biopsy Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
